Seminars in Cancer Biology

Introduction; interferons’ connection to cancer
pp. 69-72(4)
Author: Pitha P.M.

The interferon regulatory factors and oncogenesis
pp. 73-81(9)
Authors: Tanaka N.; Taniguchi T.

Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling
pp. 83-92(10)
Authors: Prejean C.; Colamonici O.R.

Novel functions of interferon-induced proteins
pp. 93-101(9)
Author: Sen G.C.

The interferons and cell death: guardians of the cell or accomplices of apoptosis?
pp. 103-111(9)
Author: Barber G.N.

Immune-inflammatory mechanisms in IFN-mediated anti-tumor activity
pp. 113-123(11)
Authors: Tannenbaum C.S.; Hamilton T.A.

Second-generation interferons for cancer: clinical targets
pp. 125-144(20)
Authors: Borden E.C.; Lindner D.; Dreicer R.; Hussein M.; Peereboom D.

Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications
pp. 145-157(13)
Authors: Ferrantini M.; Belardelli F.